Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1140

1.

Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

Choi J, Tantisira KG, Duan QL.

Pharmacogenomics J. 2018 Sep 14. doi: 10.1038/s41397-018-0048-y. [Epub ahead of print]

PMID:
30214008
2.

Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies.

Robinson KM, Yang W, Haidar CE, Hankins JS, Jay DW, Kornegay N, Rubnitz JE, Broeckel U, Cheng C, Pui CH, Jeha S, Relling MV.

Pharmacogenomics J. 2018 Sep 12. doi: 10.1038/s41397-018-0043-3. [Epub ahead of print]

PMID:
30206300
3.

An optimized prediction framework to assess the functional impact of pharmacogenetic variants.

Zhou Y, Mkrtchian S, Kumondai M, Hiratsuka M, Lauschke VM.

Pharmacogenomics J. 2018 Sep 12. doi: 10.1038/s41397-018-0044-2. [Epub ahead of print]

PMID:
30206299
4.

A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma.

Spear ML, Hu D, Pino-Yanes M, Huntsman S, Eng C, Levin AM, Ortega VE, White MJ, McGarry ME, Thakur N, Galanter J, Mak ACY, Oh SS, Ampleford E, Peters SP, Davis A, Kumar R, Farber HJ, Meade K, Avila PC, Serebrisky D, Lenoir MA, Brigino-Buenaventura E, Cintron WR, Thyne SM, Rodriguez-Santana JR, Ford JG, Chapela R, Estrada AM, Sandoval K, Seibold MA, Winkler CA, Bleecker ER, Myers DA, Williams LK, Hernandez RD, Torgerson DG, Burchard EG.

Pharmacogenomics J. 2018 Sep 12. doi: 10.1038/s41397-018-0042-4. [Epub ahead of print]

PMID:
30206298
5.

Hydroxyurea in the management of sickle cell disease: pharmacogenomics and enzymatic metabolism.

Yahouédéhou SCMA, Adorno EV, da Guarda CC, Ndidi US, Carvalho SP, Santiago RP, Aleluia MM, de Oliveira RM, Gonçalves MS.

Pharmacogenomics J. 2018 Sep 12. doi: 10.1038/s41397-018-0045-1. [Epub ahead of print]

PMID:
30206297
6.

Race and precision medicine: is it time for an upgrade?

Roman YM.

Pharmacogenomics J. 2018 Sep 10. doi: 10.1038/s41397-018-0046-0. [Epub ahead of print] No abstract available.

PMID:
30197415
7.

Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art.

Szejniuk WM, Robles AI, McCulloch T, Falkmer UGI, Røe OD.

Pharmacogenomics J. 2018 Sep 7. doi: 10.1038/s41397-018-0029-1. [Epub ahead of print] Review.

PMID:
30190521
8.

BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.

Huang E, Hettige NC, Zai G, Tomasi J, Huang J, Zai CC, Pivac N, Nikolac Perkovic M, Tiwari AK, Kennedy JL.

Pharmacogenomics J. 2018 Sep 5. doi: 10.1038/s41397-018-0041-5. [Epub ahead of print]

PMID:
30181602
9.

Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis.

Massey J, Plant D, Hyrich K, Morgan AW, Wilson AG, Spiliopoulou A, Colombo M, McKeigue P, Isaacs J, Cordell H, Pitzalis C, Barton A; BRAGGSS, MATURA Consortium.

Pharmacogenomics J. 2018 Aug 31. doi: 10.1038/s41397-018-0040-6. [Epub ahead of print]

PMID:
30166627
10.

A non-functional galanin receptor-2 in a multiple sclerosis patient.

Garcia-Rosa S, Trivella DB, Marques VD, Serafim RB, Pereira JG, Lorenzi JC, Molfetta GA, Christo PP, Olival GS, Marchitto VB, Brum DG, Sabedot TS, Noushmehr H, Farias AS, Santos LM, Nogueira-Machado JA, Souza JE, Romano CM, Conde RM, Santos AC, Guerreiro CT, Schreuder WH, Gleber-Netto FO, Amorim M, Valieris R, Silva ITD, Silva WA Jr, Nunes DN, Oliveira PS, Valente V, Arruda MA, Hill SJ, Barreira AA, Dias-Neto E.

Pharmacogenomics J. 2018 Aug 22. doi: 10.1038/s41397-018-0032-6. [Epub ahead of print]

PMID:
30131588
11.

An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.

Soko ND, Chimusa E, Masimirembwa C, Dandara C.

Pharmacogenomics J. 2018 Aug 13. doi: 10.1038/s41397-018-0035-3. [Epub ahead of print]

PMID:
30100615
12.

Cross-ethnicity tagging SNPs for HLA alleles associated with adverse drug reaction.

Erlichster M, Goudey B, Skafidas E, Kwan P.

Pharmacogenomics J. 2018 Aug 10. doi: 10.1038/s41397-018-0039-z. [Epub ahead of print]

PMID:
30093715
13.

Polymorphisms in CEP68 gene associated with risk of immediate selective reactions to non-steroidal anti-inflammatory drugs.

Perkins JR, Acosta-Herrera M, Plaza-Serón MC, Jurado-Escobar R, Doña I, García-Martín E, Isidoro-García M, Bartra J, Ribas-Perez D, Mayorga C, Torres MJ, Flores C, Cornejo-García JA.

Pharmacogenomics J. 2018 Aug 10. doi: 10.1038/s41397-018-0038-0. [Epub ahead of print]

PMID:
30093714
14.

Frequency of vitamin K oxidoreductase complex subunit-1 (VKORC1) polymorphisms and warfarin dose management in patients with venous thromboembolism.

Kabalak PA, Savaş İ, Akar N, Demir N, Eğin Y.

Pharmacogenomics J. 2018 Aug 10. doi: 10.1038/s41397-018-0037-1. [Epub ahead of print]

PMID:
30093713
15.

Two common mutations within CYP2C19 affected platelet aggregation in Chinese patients undergoing PCI: a one-year follow-up study.

Wang Z, Liu Z, Wang W, Fu Y, Chen W, Li W, Zhang X, Tang Y, Zhou Z.

Pharmacogenomics J. 2018 Jul 31. doi: 10.1038/s41397-018-0036-2. [Epub ahead of print]

PMID:
30061570
16.

Pharmacogenetics of ugt genes in North African populations.

Gaibar M, Novillo A, Romero-Lorca A, Esteban ME, Fernández-Santander A.

Pharmacogenomics J. 2018 Jul 31. doi: 10.1038/s41397-018-0034-4. [Epub ahead of print] No abstract available.

PMID:
30061569
17.

Variation within voltage-gated calcium channel genes and antipsychotic treatment response in a South African first episode schizophrenia cohort.

O'Connell KS, McGregor NW, Malhotra A, Lencz T, Emsley R, Warnich L.

Pharmacogenomics J. 2018 Jul 22. doi: 10.1038/s41397-018-0033-5. [Epub ahead of print]

PMID:
30032160
18.

UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder.

Hongkaew Y, Medhasi S, Pasomsub E, Ngamsamut N, Puangpetch A, Vanwong N, Chamnanphon M, Limsila P, Suthisisang C, Wilffert B, Sukasem C.

Pharmacogenomics J. 2018 Jun 29. doi: 10.1038/s41397-018-0031-7. [Epub ahead of print]

PMID:
29955115
19.

Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer.

Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Cremolini C, Lonardi S, Bergamo F, Ning Y, Yamamoto N, Okazaki S, Berger MD, Miyamoto Y, Gopez R Jr, Barzi A, Yamaguchi T, Stintzing S, Heinemann V, Loupakis F, Falcone A, Lenz HJ.

Pharmacogenomics J. 2018 Jun 21. doi: 10.1038/s41397-018-0030-8. [Epub ahead of print]

PMID:
29925895
20.

Genome-wide meta-analysis of SNP-by9-ACEI/ARB and SNP-by-thiazide diuretic and effect on serum potassium in cohorts of European and African ancestry.

Irvin MR, Sitlani CM, Noordam R, Avery CL, Bis JC, Floyd JS, Li J, Limdi NA, Srinivasasainagendra V, Stewart J, de Mutsert R, Mook-Kanamori DO, Lipovich L, Kleinbrink EL, Smith A, Bartz TM, Whitsel EA, Uitterlinden AG, Wiggins KL, Wilson JG, Zhi D, Stricker BH, Rotter JI, Arnett DK, Psaty BM, Lange LA.

Pharmacogenomics J. 2018 Jun 1. doi: 10.1038/s41397-018-0021-9. [Epub ahead of print]

PMID:
29855607

Supplemental Content

Loading ...
Support Center